We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiosurgery Effective for Treatment of Spinal Tumors

By HospiMedica staff writers
Posted on 22 Jan 2003
Following the treatment of 100 patients with spinal tumors, doctors have found that stereotactic radiosurgery using the CyberKnife can be performed safely, accurately, and effectively.

Stereotactic radiosurgery involves the use of precise targeting and multiple beams of high-dose radiation to ablate tumors and other lesions noninvasively. More...
The CyberKnife can perform single-session or staged radiosurgery on lesions located anywhere in the body through the use of image guidance and robotics. The treatment of 100 patients took place over the last 14 months at the University of Pittsburgh Medical Center (UPMC, PA, USA).

"The major potential benefits of radiosurgical ablation of spinal lesions are short treatment time in an outpatient setting with no recovery time and good treatment effect,” said Peter Gerstzen, M.D., M.P.H., assistant professor of neurosurgery at the University of Pittsburgh. Dr. Gerstzen has pioneered spinal treatments with the CyberKnife at UPMC.

In the past, radiosurgery was used primarily to treat brain lesions because it required the use of a metal frame to achieve accuracy in radiation targeting. The CyberKnife replaces the frame with an advanced image-guidance system that uses bony landmarks or small, embedded markers to target the radiation. The CyberKnife is manufactured and distributed worldwide by Accuray, Inc. (Sunnyvale, CA, USA).





Related Links:
UPMC
Accuray

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.